SRP0233
PI3 kinase (p110a/p85a) Active human
recombinant, expressed in baculovirus infected insect cells, ≥80% (SDS-PAGE)
别名:
PI3-kinase regulatory subunit 4, PIK3R4, Phosphoinositide 3-kinase adaptor protein, VPS15, PIK3CA, Phosphoinositide-3-kinase, catalytic, alpha, PtdIns-3-kinase p110
登录查看公司和协议定价
所有图片(2)
About This Item
推荐产品
生物源
human
重組細胞
expressed in baculovirus infected insect cells
化驗
≥80% (SDS-PAGE)
形狀
aqueous solution
比活性
≥13 pmol/min-μg
分子量
129 kDa (p110α)
88 kDa (p85α)
包裝
pkg of 20 μg
製造商/商標名
Sigma-Aldrich
濃度
>0.02 mg/mL
技術
activity assay: suitable
UniProt登錄號
應用
life science and biopharma
運輸包裝
dry ice
儲存溫度
−70°C
基因資訊
human ... PIK3CA(5290)
一般說明
Research area: Cell Signaling
PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit a) is one of the four subunits of the 110kDa catalytic subunit of PI3K protein, which contains a regulatory region of 85kDa. PI3K proteins form a family of lipid kinases. This gene is localized to human chromosome 3q.Three different classes of PI3Ks (I – III) have been discovered.
PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit a) is one of the four subunits of the 110kDa catalytic subunit of PI3K protein, which contains a regulatory region of 85kDa. PI3K proteins form a family of lipid kinases. This gene is localized to human chromosome 3q.Three different classes of PI3Ks (I – III) have been discovered.
應用
PI3 kinase (p110a/p85a) Active human has been used for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.
生化/生理作用
PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit a) is one of the four catalytic subunits of PI3K protein, which plays an essential role in extracellular growth signaling. It phosphorylates and activates protein kinase B (PKB) protein. This protein has a wide range of physiological functions, such as proliferation, cell cycle, survival, adhesion, motility, apoptosis, angiogenesis, DNA repair, senescence, and cellular metabolism, and plays a central role in multiple types of cancers. It also functions as an intermediary in cellular signaling and is primarily recognized for its involvement in the Phosphoinositide 3-kinase/ Protein kinase B/ mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway. PIK3CA gene is either mutated or amplified in brain, breast, stomach, liver, ovary, and colon cancers. Mutation in this gene leads to enhanced PI3K activity, and it is a candidate transforming oncogene. It is over-expressed in invasive breast cancer and is a marker for poor prognosis. This gene is amplified in high-grade dysplastic lesions from bronchial biopsy specimens obtained from preinvasive squamous lung cancer. Frequency of mutations in the PIK3CA gene is higher in tumors without lymph node metastasis than in those with gastric cancer. Thus, it might be essential to evaluate the mutations in this gene to determine cetuximab treatment in gastric cancer patients.
單位定義
One unit of 110a/p85a kinase activity is defined as the amount of enzyme required to produce 1 pmol of Phosphoinositol-3, 4,5-Trisphosphate/min at 37°C.
外觀
Formulated in 25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.05% Tween-20, 30% glycerol and 3 mM DTT.
準備報告
Thaw on ice. Upon first thaw, briefly spin tube containing enzyme to recover full content of the tube. Aliquot enzyme into single use aliquots. Store remaining undiluted enzyme in aliquots at -70°C. Note: Enzyme is very sensitive to freeze/thaw cycles.
儲存類別代碼
10 - Combustible liquids
水污染物質分類(WGK)
WGK 1
PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
Breast Cancer Research and Treatment, 122(1), 45-53 (2010)
Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.
American Journal of Respiratory and Critical Care Medicine, 182(1), 83-91 (2010)
Molecular medicine reports, 12(1), 1219-1224 (2015-03-31)
Cetuximab, an immunoglobulin G1 chimeric monoclonal antibody directed against the epidermal growth factor receptor, is currently considered to be the strategy with the most potential for the treatment of gastric cancer due to the low frequency of KRAS mutations in
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门